Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Prenetics Global (PRENW) Cash & Equivalents (2021 - 2025)

Historic Cash & Equivalents for Prenetics Global (PRENW) over the last 5 years, with Q3 2025 value amounting to $13.3 million.

  • Prenetics Global's Cash & Equivalents fell 5847.1% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year decrease of 5847.1%. This contributed to the annual value of $45.4 million for FY2024, which is 65.64% down from last year.
  • Per Prenetics Global's latest filing, its Cash & Equivalents stood at $13.3 million for Q3 2025, which was down 5847.1% from $17.2 million recorded in Q2 2025.
  • Prenetics Global's 5-year Cash & Equivalents high stood at $177.2 million for Q2 2023, and its period low was $992169.4 during Q4 2023.
  • Over the past 5 years, Prenetics Global's median Cash & Equivalents value was $40.3 million (recorded in 2024), while the average stood at $62.3 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first crashed by 8356.61% in 2023, then surged by 447643.62% in 2024.
  • Prenetics Global's Cash & Equivalents (Quarter) stood at $35.3 million in 2021, then tumbled by 82.89% to $6.0 million in 2022, then tumbled by 83.57% to $992169.4 in 2023, then skyrocketed by 4476.44% to $45.4 million in 2024, then tumbled by 70.79% to $13.3 million in 2025.
  • Its Cash & Equivalents was $13.3 million in Q3 2025, compared to $17.2 million in Q2 2025 and $43.2 million in Q1 2025.